Home › NDC Lookup › RxCUI directory › RxCUI 2272621

{1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray) } Pack — RxCUI 2272621

RxNorm drug concept · Generic pack
RxCUI 2272621 Generic pack · GPCK ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2272621
Official name{1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known asdiazepam 10 MG per 0.1 mL Nasal Spray Dose Kit; diazePAM 10 MG in 0.1 mL Nasal Spray Dose Kit
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)168,039 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diazepam Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It’s a rescue medicine for clusters of seizures in people with epilepsy age 2 and older. These are episodes that look different from the person’s usual seizures. It is used along w...
  • Usually a trained caregiver gives it rectally with the prefilled applicator. A second dose may be given 4 to 12 hours later if your prescriber ordered it. It should be used for no...
  • Who gives it, and how often can it be used?
  • Sleepiness is the most common, so plan for rest and no driving. Dizziness, headache, stomach upset, unsteadiness, and rash can also happen. Call for emergency help if breathing bec...
📖 Read our full Diazepam Rectal guide →

🕸️ Concept Web — How {1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray) } P... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {1 (0.1 ML) (diazepam 100 MG/ML Nasal Spray) } Pack RxCUI 2272621

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Diazepam 3322
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Valtoco 2272614
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Diazepam Nasal Spray 2272612
    • Diazepam Inhalant Product 2272610
    • Diazepam Nasal Product 2272611
    • Diazepam Nasal Spray [Valtoco] 2272616
    • Valtoco Inhalant Product 2272617
    • Valtoco Nasal Product 2272618
    • Pack 746839
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Diazepam 100 MG/ML Nasal Spray SCD · 2272613
  • Diazepam 100 MG/ML SCDC · 2272609
  • Diazepam Nasal Spray SCDF · 2272612
  • Diazepam Inhalant Product SCDG · 2272610
  • Diazepam Nasal Product SCDG · 2272611

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 2272621 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72252-0505-02 2 BLISTER PACK in 1 CARTON (72252-505-02) / 1 VIAL, SINGLE-... Valtoco Neurelis, Inc 2020-01-10
72252-0505-05 5 BLISTER PACK in 1 CARTON (72252-505-05) / 1 VIAL, SINGLE-... Valtoco Neurelis, Inc 2025-02-28
72252-0510-02 2 BLISTER PACK in 1 CARTON (72252-510-02) / 1 VIAL, SINGLE-... Valtoco Neurelis, Inc 2020-01-10
72252-0510-05 5 BLISTER PACK in 1 CARTON (72252-510-05) / 1 VIAL, SINGLE-... Valtoco Neurelis, Inc 2025-02-28
72252-0515-04 2 BLISTER PACK in 1 CARTON (72252-515-04) / 2 VIAL, SINGLE-... Valtoco Neurelis, Inc 2020-01-10
72252-0515-10 5 BLISTER PACK in 1 CARTON (72252-515-10) / 2 VIAL, SINGLE-... Valtoco Neurelis, Inc 2025-02-28
72252-0520-04 2 BLISTER PACK in 1 CARTON (72252-520-04) / 2 VIAL, SINGLE-... Valtoco Neurelis, Inc 2020-01-10
72252-0520-10 2 BLISTER PACK in 1 CARTON (72252-520-10) / 2 VIAL, SINGLE-... Valtoco Neurelis, Inc 2025-02-28
Observed labelers: Neurelis, Inc (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.